For the year ending 2025-12-31, CPRX made $588,989K in revenue. $214,262K in net income. Net profit margin of 36.38%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 588,989 | |||
| Cost of sales | 87,253 | |||
| Research and development | 12,709 | |||
| Selling, general and administrative | 193,751 | |||
| Amortization of intangible assets | 37,498 | |||
| Total operating costs and expenses | 331,211 | |||
| Operating income | 257,778 | |||
| Other income, net | 25,737 | |||
| Net income before income taxes | 283,515 | |||
| Income tax provision | 69,189 | |||
| Net income | 214,326 | |||
| Unrealized gain (loss) on available-for-sale securities, net of tax of 0, (20) and 4, respectively | -64 | |||
| Comprehensive income | 214,262 | |||
| Basic EPS | 1.75 | |||
| Diluted EPS | 1.68 | |||
| Basic Average Shares | 122,290,866 | |||
| Diluted Average Shares | 127,257,929 | |||
CATALYST PHARMACEUTICALS, INC. (CPRX)
CATALYST PHARMACEUTICALS, INC. (CPRX)